This suggests that AGTR1 could be a potential therapeutic target for EM (43).However, in our clinical sample validation, the expression level of ATGR1 in EC was lower than in EU and normal endometrium, which could be attributed to endometriosis heterogeneity and the small sample size. Here, AGTR1 is linked to erythema multiforme.